Cargando…

Myocardial T2 signal enhancement in hypertrophic cardiomyopathy: prevalence, clinical profile and pathologic correlation

Detalles Bibliográficos
Autores principales:	Kolman, Louis, Stirrat, John, Rajchl, Martin, Joncas, Sebastien X, Mikami, Yoko, Tweedie, Edward J, Flewitt, Jacqueline, Lydell, Carmen, Howarth, Andrew G, White, James A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043200/ http://dx.doi.org/10.1186/1532-429X-16-S1-O85

Ejemplares similares

Accuracy and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy
por: Mikami, Yoko, et al.
Publicado: (2014)

Precision and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy
por: Mikami, Yoko, et al.
Publicado: (2014)

Prognostic significance of the extent of septal fibrosis quantified on late gadolium enhanced images in patients with nonischemic cardiomyopathy
por: Cornhill, Aidan K, et al.
Publicado: (2015)

Differentiation of physiologic versus pathologic basal septal fibrosis: Proposed diagnostic criteria and associations with clinical and CMR-based markers of cardiovascular disease
por: Joncas, Sebastien X, et al.
Publicado: (2014)

Objective criteria for septal fibrosis in non-ischemic dilated cardiomyopathy: validation for the prediction of future cardiovascular events
por: Mikami, Yoko, et al.
Publicado: (2016)

Neural-Network-Based Diagnosis Using 3-Dimensional Myocardial Architecture and Deformation: Demonstration for the Differentiation of Hypertrophic Cardiomyopathy
por: Satriano, Alessandro, et al.
Publicado: (2020)

Refining the characterization of residual function in hypertrophic cardiomyopathy through remote segment 4D strain analysis
por: Satriano, Alessandro, et al.
Publicado: (2016)

Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy
por: Hussain, Tarique, et al.
Publicado: (2013)

Mid-wall striae fibrosis predicts heart failure admission, composite heart failure events, and life-threatening arrhythmias in dilated cardiomyopathy
por: Purmah, Yanish, et al.
Publicado: (2022)

Influence of phase correction of late gadolinium enhancement images on scar signal quantification in patients with ischemic and non-ischemic cardiomyopathy
por: Stirrat, John, et al.
Publicado: (2015)

Markers of abnormal tissue deformation and fibrosis in remote myocardium following acute myocardial infarction: a comparison of diabetics versus non-diabetics performed using spatially matched 4D strain and native T1 mapping
por: Satriano, Alessandro, et al.
Publicado: (2016)

Right ventricular insertion site fibrosis in a dilated cardiomyopathy referral population: phenotypic associations and value for the prediction of heart failure admission or death
por: Mikami, Yoko, et al.
Publicado: (2021)

Comparison of Semi-automated Late Gadolinium Enhancement Quantification Techniques in Measuring Septal Fibrosis in Patients with Dilated Non-Ischemic Cardiomyopathy
por: Mikami, Yoko, et al.
Publicado: (2016)

Natural History of Myocardial Injury After COVID-19 Vaccine–Associated Myocarditis
por: Mustafa Alhussein, Muhammad, et al.
Publicado: (2022)

Effect of Active Cancer on the Cardiac Phenotype: A Cardiac Magnetic Resonance Imaging‐Based Study of Myocardial Tissue Health and Deformation in Patients With Chemotherapy‐Naïve Cancer
por: Labib, Dina, et al.
Publicado: (2021)

Relative influence of peak strain delay and peak strain amplitude of non-scarred myocardium in response to cardiac resynchronization therapy: insights from segmental 4D strain analysis
por: Satriano, Alessandro, et al.
Publicado: (2016)

Assessment of myocardial perfusion reserve with blood oxygen level-dependent cardiovascular magnetic resonance imaging
por: Flewitt, Jacqueline A, et al.
Publicado: (2009)

Role of T1 and T2-mapping in assessing the myocardial interstitium in hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study
por: Ismail, Tevfik F, et al.
Publicado: (2013)

Left atrial volume and function are predictive of cardiac death or appropriate device therapy in patients with non-ischemic dilated cardiomyopathy
por: Arasaratnam, Punitha, et al.
Publicado: (2016)

T1 mapping in discrimination between hypertrophic and hypertensive cardiomyopathy
por: Hinojar, Rocio, et al.
Publicado: (2014)

A systematic review for sudden cardiac death in hypertrophic cardiomyopathy patients with myocardial fibrosis: a CMR LGE study
por: Silva, Nackle J, et al.
Publicado: (2012)

Clinical significance of late gadolinium enhancement in pediatric patients with hypertrophic cardiomyopathy
por: Smith, Brandon M, et al.
Publicado: (2013)

Influence of Sex-Based Differences in Cardiac Phenotype on Atrial Fibrillation Recurrence in Patients Undergoing Pulmonary Vein Isolation
por: Yakimenka, Alena, et al.
Publicado: (2022)

Incremental predictive value of deep crypts in the basal inferoseptum in the setting of hypertrophic cardiomyopathy
por: Deva, Djeven P, et al.
Publicado: (2013)

Preclinical alterations in cardiac energetics amongst sarcomere mutation carriers in hypertrophic cardiomyopathy
por: Lloyd, Rachael, et al.
Publicado: (2015)

T2 abnormalities in patients with hypertrophic cardiomyopathy characterized by cardiovascular magnetic resonance imaging- an indicator of myocardial injury as assessed by the high sensitive cardiac troponin T assay
por: Lehrke, Stephanie, et al.
Publicado: (2012)

Quantitative of myocardial extracellular volume fraction improves characterization of fibrotic burden in patients with apical hypertrophic cardiomyopathy beyond visual assessment with late gadolinium enhancement
por: Watanabe, Eri, et al.
Publicado: (2012)

Exercise and myocardial injury in hypertrophic cardiomyopathy
por: Cramer, G Etienne, et al.
Publicado: (2020)

Influence of anterior mitral valve length and septal wall thickness on the prevalence of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
por: Morant, Kareem, et al.
Publicado: (2012)

Stress cardiomyopathy in a patient with hypertrophic cardiomyopathy and myocardial bridging
por: Benavides, Miguel, et al.
Publicado: (2017)

Screening for hypertrophic cardiomyopathy: a cost analysis of echocardiography, cardiac magnetic resonance and genetic testing
por: Hauser, Thomas H, et al.
Publicado: (2009)

4D strain analysis within non-infarcted myocardium of patients with ischemic cardiomyopathy: potential marker for the prediction of adverse cardiac events
por: Satriano, Alessandro, et al.
Publicado: (2016)

Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy
por: He, Yi, et al.
Publicado: (2010)

Multiplanar 4D strain analysis with spatial mapping to 3D LGE quantification: relationships in chronic Ischemic Cardiomyopathy
por: Satriano, Alessandro, et al.
Publicado: (2015)

Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy
por: Ismail, Tevfik F, et al.
Publicado: (2013)

Advanced assessment of cardiac morphology and prediction of gene carriage by CMR in hypertrophic cardiomyopathy - the HCMNet/UCL collaboration
por: Captur, Gaby, et al.
Publicado: (2014)

Machine Learning Patient-Specific Prediction of Heart Failure Hospitalization Using Cardiac MRI-Based Phenotype and Electronic Health Information
por: Cornhill, Aidan K., et al.
Publicado: (2022)

A new variant of apical hypertrophic cardiomyopathy? T wave inversion and relative but not absolute apical left ventricular hypertrophy
por: Flett, Andrew, et al.
Publicado: (2013)

An Unusual Presentation of a Myocardial Crypt in Hypertrophic Cardiomyopathy
por: van de Sande, Danny A. J. P., et al.
Publicado: (2014)

T(1) mapping for characterization of myocardial fibrosis in hypertrophic cardiomyopathy
por: Liu, Ying, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q5uqr6evp9heulqn75ajfu03j7